X-18642105-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000330.4(RS1):c.574C>A(p.Pro192Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P192L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000330.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RS1 | NM_000330.4 | c.574C>A | p.Pro192Thr | missense_variant | 6/6 | ENST00000379984.4 | NP_000321.1 | |
RS1 | XM_047442337.1 | c.478C>A | p.Pro160Thr | missense_variant | 4/4 | XP_047298293.1 | ||
CDKL5 | NM_001037343.2 | c.2714-3902G>T | intron_variant | NP_001032420.1 | ||||
CDKL5 | NM_003159.3 | c.2714-3902G>T | intron_variant | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RS1 | ENST00000379984.4 | c.574C>A | p.Pro192Thr | missense_variant | 6/6 | 1 | NM_000330.4 | ENSP00000369320.3 | ||
CDKL5 | ENST00000379989.6 | c.2714-3902G>T | intron_variant | 1 | ENSP00000369325.3 | |||||
CDKL5 | ENST00000379996.7 | c.2714-3902G>T | intron_variant | 1 | ENSP00000369332.3 | |||||
RS1 | ENST00000476595.1 | n.1065C>A | non_coding_transcript_exon_variant | 5/5 | 1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 22, 2022 | This variant disrupts the p.Pro192 amino acid residue in RS1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10533068, 28348004, 30551202, 30652005). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RS1 protein function. ClinVar contains an entry for this variant (Variation ID: 98989). This missense change has been observed in individual(s) with X-linked juvenile retinoschisis (PMID: 12457918). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 192 of the RS1 protein (p.Pro192Thr). - |
not provided, no classification provided | literature only | Retina International | - | - - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at